BTRC and neoplasm: In lung cancer (LUAD) and renal cancer (KIRC), high expression of FBXW1 is associated with reduced infiltration of immunocompetent cells such as NK cells and CD8+T cells, suggesting that it may promote immunosuppression in the microenvironment by inhibiting anti-tumor immune responses (14).